Metraipolis › archive › dc_febb06a07924
Heart failure outcomes and empagliflozin effects in patients with heart failure and reduced ejection fraction in sinus rhythm or atrial fibrillation: Data… — Europe PMC PMID:40956156
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40956156
- DOI
- 10.1002/ejhf.70021
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T22:22:33.060Z
- SHA-256 of the archived text
c20914183e36be6fee9dcb76360033798f6796352e14d991de7c475ef079ac9e- Stable URL of this page
https://metraipolis.com/documento/dc_febb06a07924
How to cite
Heart failure outcomes and empagliflozin effects in patients with heart failure and reduced ejection fraction in sinus rhythm or atrial fibrillation: Data… — Europe PMC PMID:40956156 — Europe PMC (en), https://europepmc.org/article/MED/40956156 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_febb06a07924 (Metraipolis archive dc_febb06a07924, sha256 c20914183e36be6fee9dcb76360033798f6796352e14d991de7c475ef079ac9e)
BibTeX
@misc{dcfebb06a07924,
title = {Heart failure outcomes and empagliflozin effects in patients with heart failure and reduced ejection fraction in sinus rhythm or atrial fibrillation: Data… — Europe PMC PMID:40956156},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40956156},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_febb06a07924; sha256 c20914183e36be6fee9dcb76360033798f6796352e14d991de7c475ef079ac9e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40956156. Agents can read the archived copy with the MCP tool read_document.